Michael Bettess

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia.

Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb.

Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia.

Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland.